Entheon Biomedical (XCNQ:ENBI) Price-to-Operating-Cash-Flow : (As of Apr. 30, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Price-to-Operating-Cash-Flow?

As of today (2024-04-30), Entheon Biomedical's share price is C$0.16. Entheon Biomedical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2023 was C$-0.06. Hence, Entheon Biomedical's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Entheon Biomedical's Price-to-Operating-Cash-Flow or its related term are showing as below:

XCNQ:ENBI's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.83
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Entheon Biomedical's Cash Flow from Operations per share for the three months ended in Nov. 2023 was C$-0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2023 was C$-0.06.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 28.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 12.30% per year.

During the past 7 years, Entheon Biomedical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 28.80% per year. The lowest was -223.30% per year. And the median was -34.75% per year.

Entheon Biomedical Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Entheon Biomedical's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Price-to-Operating-Cash-Flow Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Entheon Biomedical Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Entheon Biomedical's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Entheon Biomedical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entheon Biomedical's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Price-to-Operating-Cash-Flow falls into.

Entheon Biomedical Price-to-Operating-Cash-Flow Calculation

Entheon Biomedical's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.16	/	-0.061
	=

Entheon Biomedical's Share Price of today is C$0.16.
Entheon Biomedical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.06.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Entheon Biomedical Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines